CoChat

Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type

Open access
Popp, Julius, Wolfsgruber, Steffen, Heuser, Isabella, Peters, Oliver, Hüll, Michael, Schröder, Johannes, Möller, Hans-Jürgen, Lewczuk, Piotr, Schneider, Anja, Jahn, Holger, Luckhaus, Christian, Perneczky, Robert, Frölich, Lutz, Wagner, Michael, Maier, Wolfgang, Wiltfang, Jens, Kornhuber, Johannes, Jessen, Frank · 2015 · Neurobiology of Aging
Cited by 169

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Increased peripheral and central nervous system cortisol levels have been reported in Alzheimer's disease (AD) and may reflect dysfunction of cerebral components of the hypothalamic-pituitary-adrenal (HPA) axis. However, brain exposure to high cortisol concentrations may also accelerate disease progression and cognitive decline. The objectives of this study were to investigate whether HPA-axis dysregulation occurs at early clinical stages of AD and whether plasma and CSF cortisol levels are associated with clinical disease progression. Morning plasma and CSF cortisol concentrations were obtained from the subjects with AD dementia, mild cognitive impairment of AD type (MCI-AD), MCI of other type (MCI-O), and controls with normal cognition included in a multicenter study from the German Dementia Competence Network. A clinical and neuropsychological follow-up was performed in a subgroup of participants with MCI-AD, MCI-O, and AD dementia. CSF cortisol concentrations were increased in the subjects with AD dementia or MCI-AD compared with subjects with MCI-O or normal cognition. After controlling for possible confounders including CSF measures of amyloid beta1-42 and total tau, higher baseline CSF cortisol levels were associated with faster clinical worsening and cognitive decline in MCI-AD. The findings suggest that HPA-axis dysregulation occurs at the MCI stage of AD and may accelerate disease progression and cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2014.10.031

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 169

Metadata

Authors
Popp, J., Wolfsgruber, S., Heuser, I., Peters, O., Hüll, M., Schröder, J., Möller, H.-J., Lewczuk, P., Schneider, A., Jahn, H., Luckhaus, C., Perneczky, R., Frölich, L., Wagner, M., Maier, W., Wiltfang, J., Kornhuber, J., & Jessen, F.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2015-02
Volume
36
Issue
2
Pages
601-607
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2151466405
Cited by
169
References
11
FWCI
6.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2014.10.031
The paper
Popp, J., Wolfsgruber, S., Heuser, I., Peters, O., Hüll, M., Schröder, J., Möller, H.-J., Lewczuk, P., Schneider, A., Jahn, H., Luckhaus, C., Perneczky, R., Frölich, L., Wagner, M., Maier, W., Wiltfang, J., Kornhuber, J., & Jessen, F. (2015). Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2014.10.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.